Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis have?
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis has 1,414 citations in the OpenAlex counts ScholarIQ stores.
When was Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis published?
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis has 2014 year in the ScholarIQ index.
What is the open-access status of Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis?
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis has closed oa status in the ScholarIQ index.
What is the DOI of Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis?
The DOI for Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis is on the source record.
What is the PMID of Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis?
The PMID for Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis is on the source record.
What is the OpenAlex record for Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis?
The OpenAlex for Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis is on the source record.